🔥Telegram İfşa

Editorial: "Ultimately, new treatments such as donanemab will not only change the Alzheimer research landscape but also the clinical one." ja.ma/47kMtdl Eric Widera, MD Sharon Brangman Nathaniel Chin

What is the role of individuals like geriatricians in prescribing #Amyloid Antibodies & caring for individuals who are receiving them? This and much more. Guests Nathaniel Chin, Sharon Brangman, & @jasonkarlawish. Episode bit.ly/GeriPalEp276 - hosts Alex Smith, MD | Eric Widera, MD

Nearly three years after publication, “Intermittent Fasting and its Effects on the Brain” continues to be among the most downloaded episodes of #DementiaMatters. Listen to the podcast: go.wisc.edu/355mo3

REGISTRATION IS OPEN for our 21st Annual #AlzheimersDisease and Related #dementias Update on November 2 -3, 2023. We have a GREAT line-up of speakers and topics for this year's event. Use this link to register: wai.wisc.edu/adrdupdate/#re… (hybrid option available for November 3)

Join us for the 2023 Fall Community Conversation on September 21, also known as #WorldAlzheimersDay! Free and open to all, the event will feature a resource fair and talks from UW–Madison faculty on new #Alzheimers treatments. Register and learn more at adrc.wisc.edu/fcc2023

Today is #WorldAlzheimersDay. Learn about new treatments for Alzheimer’s disease when you attend the Fall Community Conversation TONIGHT at the Middleton Performing Arts Center. Walk-ins are welcome and plenty of free parking will be available. Learn more: adrc.wisc.edu/fcc2023

Advances in #Alzheimersdisease are changing our clinics. But before new tools can be used, people need a diagnosis. Learn strategies to evaluate cognitive change, earn CMEs & connect with Nathaniel Chin and Dan McCully, MD about navigating #memorycare. go.wisc.edu/e6563i

Get the inside scoop from the Wisconsin ADRC, check out the latest edition of 'Headlines' online at: mailchi.mp/medicine.wisc.… #WisconsinIdea #Alzheimers

Thank you to Carl V. Hill for joining me on #DementiaMatters back in August. Diversity and inclusion are crucial to ensuring that scientific findings from Alzheimer's research are equitable and beneficial for everyone. Thanks for sharing your insight on this important topic with us.

Thank you Percy Griffin for joining me on #DementiaMatters last month to discuss highlights from #AAIC2023 in Amsterdam. It was great to have you back on the podcast and learn more about the latest developments in Alzheimer's research.

Thank you for joining #DementiaMatters again, Art Walaszek. It was a pleasure to have you on the podcast again and share this important information with our listeners, especially for our first accredited episode. Tune in and learn more at the link below.

And we enjoyed having you on #DementiaMatters, Beth Fields. Thanks for sharing your work in geriatrics health services and caregiving research, as well as so many great resources, with our listeners. Be sure to tune in at go.wisc.edu/p8857w.

Thank you, Dr. Doraiswamy, for joining me on #DementiaMatters. It was wonderful to learn about your study, done in collaboration with Columbia University, and hear just how helpful #crosswords and cognitive engagement can be for brain health.

Thank you Alison Huang PhD for joining #DementiaMatters. Social interaction plays an important role in brain health, and your work does a great job highlighting these key factors. Thanks for sharing your insights and findings with our listeners.

The difference between Alzheimer's and dementia is becoming increasingly more important.

Nice summary from Dr Sam Moxon highlighting the importance of food in brain health. I look forward to more bite sized and impactful information from the Nutrition, Metabolism and Dementia PIA.

Check out the latest edition of “News for Memorable Friends,” where you can watch the recording of the UW Now Leading the Way on Alzheimer’s Research livestream and get details on the latest from #Alzheimers disease research programs at UW–Madison. Visit: mailchi.mp/supportuw.org/…

#Alzheimers affects an estimated 6.9 million Americans age 65 and older. If you appreciate the news, research and caregiver resources we provide on the #DementiaMatters podcast, consider donating to our fund through the @uwfoundation. Visit: supportuw.org/giveto/dementi…

Thank you Scott Roberts for a great conversation on APOE testing and sharing results with research participants. Your insights will be helpful as the clinical field incorporates this testing more. The evaluation for using novel anti-amyloid therapies has brought many changes.

I’m excited to share this perspective essay in NEJM. The role of primary care in evaluating cognitive change is critical. Biomarker testing is exciting, but it doesn’t simplify the process nor should it diminish the importance of a good history and clinical judgement.